Official EU label nameGlossary entry 15616

LUPEOL

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:545-47-1

Ingredient index records:

LUPEOL

Cosmetic functions: SKIN CONDITIONING

Crataeva Nurvala Bark/Root/Stem Extract,Crataeva Nurvala Extract,Farganasterol,(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol

Open full local profile

1 matched or reported name

LUPEOL

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name LUPEOL.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 545-47-1

CAS 545-47-1PubChem CID 259846

Lupeol

Lupeol is a pentacyclic triterpenoid that is lupane in which the hydrogen at the 3beta position is substituted by a hydroxy group. It occurs in the skin of lupin seeds, as well as in the latex of fig trees and of rubber plants. It is also found in many edible fruits and vegetables. It has a role as an anti-inflammatory drug and a plant metabolite. It is a pentacyclic triterpenoid and a secondary alcohol. It derives from a hydride of a lupane. — ChEBI

IUPAC name: (1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol

Molecular formula: C30H50O
Molecular weight: 426.7 g/mol
Exact mass: 426.386166214 Da
XLogP3: 9.9
Topological polar surface area: 20.2 Å²
Hydrogen-bond donors: 1
Hydrogen-bond acceptors: 1
Covalent units: 1
Defined stereocentres: 10

Also known as

FagarasterolClerodolMonogynol BFagarsterolLupenolTriterpene lupeolfarganasterolbeta-Viscol

16 more reported names

Lup-20(29)-en-3-ol, (3-beta)-Lup-20(29)-en-3beta-olO268W13H3ONSC-90487(3-beta)-Lup-20(29)-en-3-olCHEBI:6570Lup-20(29)-en-3-beta-olRefChem:41970208-889-9Lup-20(29)-en-3-ol, (3b)-.beta.-ViscolLup-20(29)-en-3b-olNSC 90487Lup-20(29)-en-3-ol, (3.beta.)-Lup-20(29)-en-3.beta.-olClerodol; Fagarasterol; Lupenol; Monogynol B; NSC 90487; |A-Viscol

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

ChEBI:CHEBI:6570
ChEMBL:CHEMBL289191
EPA DTXSID:DTXSID901025006
PubMed:22991570
PubMed:22978211
PubMed:22976320
PubMed:22900200
PubMed:22898386
PubMed:22837051
PubMed:22816307
PubMed:22809287
PubMed:22806881
PubMed:22792796
PubMed:22732730
PubMed:22701284

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision